BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11220371)

  • 61. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal, and immunoperoxidase staining assays.
    Halper J; Colvard DS; Scheithauer BW; Jiang NS; Press MF; Graham ML; Riehl E; Laws ER; Spelsberg TC
    Neurosurgery; 1989 Oct; 25(4):546-52; discussion 552-3. PubMed ID: 2477767
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients.
    Olivero WC; Lister JR; Elwood PW
    J Neurosurg; 1995 Aug; 83(2):222-4. PubMed ID: 7616265
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Perfusion MR imaging for differentiation of benign and malignant meningiomas.
    Zhang H; Rödiger LA; Shen T; Miao J; Oudkerk M
    Neuroradiology; 2008 Jun; 50(6):525-30. PubMed ID: 18379768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Impact of computed tomographic and magnetic resonance imaging findings on surgical outcome in petroclival meningiomas.
    Carvalho GA; Matthies C; Tatagiba M; Eghbal R; Samii M
    Neurosurgery; 2000 Dec; 47(6):1287-94; discussion 1294-5. PubMed ID: 11126899
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracytoplasmic lumina in meningioma: an ultrastructural and immunohistological study.
    Vakili ST; Muller J
    Neurosurgery; 1988 Aug; 23(2):180-4. PubMed ID: 2460798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
    Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
    Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CD68 and CR3/43 immunohistochemical expression in secretory meningiomas.
    Caffo M; Caruso G; Germanò A; Galatioto S; Meli F; Tomasello F
    Neurosurgery; 2005 Sep; 57(3):551-7; discussion 551-7. PubMed ID: 16145535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pathodiagnostic parameters for meningioma grading.
    Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
    J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cerebral edema in intracranial meningiomas: evidence for local and diffuse patterns and factors associated with its occurrence.
    Abe T; Black PM; Ojemann RG; Hedley-White ET
    Surg Neurol; 1994 Dec; 42(6):471-5. PubMed ID: 7825100
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas.
    Ding YS; Wang HD; Tang K; Hu ZG; Jin W; Yan W
    Ann Clin Lab Sci; 2008; 38(4):344-51. PubMed ID: 18988927
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipomatous meningioma.
    Ohba S; Yoshida K; Akiyama T; Ikeda E; Kawase T
    J Clin Neurosci; 2007 Oct; 14(10):1003-6. PubMed ID: 17240148
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Secretory meningioma with lipomatous component: case report.
    Yamada H; Hanada T; Okuda S; Yokota A; Haratake J
    Brain Tumor Pathol; 1999; 16(2):77-80. PubMed ID: 10746964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgical strategies for giant medial sphenoid wing meningiomas: a new scoring system for predicting extent of resection.
    Behari S; Giri PJ; Shukla D; Jain VK; Banerji D
    Acta Neurochir (Wien); 2008 Sep; 150(9):865-77; discussion 877. PubMed ID: 18754074
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Secretory meningiomas: immunohistochemical pattern of lectin and ultrastructure of pseudopsammoma bodies.
    Taraszewska A; Matyja E
    Folia Neuropathol; 2014; 52(2):141-50. PubMed ID: 25118899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Secretory meningioma. Report of two cases].
    Stávale JN; Malheiros SM; Gabbai AA
    Arq Neuropsiquiatr; 1997 Sep; 55(3A):478-81. PubMed ID: 9629368
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases.
    Jung HW; Yoo H; Paek SH; Choi KS
    Neurosurgery; 2000 Mar; 46(3):567-74; discussion 574-5. PubMed ID: 10719852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Frontotemporal clear cell meningioma. Report of 3 cases.
    Tena-Suck ML; Salinas-Lara C; Gómez C; Bojórquez DR
    Ann Diagn Pathol; 2007 Jun; 11(3):182-9. PubMed ID: 17498592
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunohistochemical expression of aromatase and estrogen, androgen and progesterone receptors in normal and neoplastic human meningeal cells.
    Leães CG; Meurer RT; Coutinho LB; Ferreira NP; Pereira-Lima JF; da Costa Oliveira M
    Neuropathology; 2010 Feb; 30(1):44-9. PubMed ID: 19703265
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
    Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
    Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.